title: Granulomatosis with polyangiitis mimicking classic inflammatory bowel disease-associated pyoderma gangrenosum.
authors.affiliation: Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Scott A
authors.initials: SA
authors.lastname: Kindle
authors.affiliation: Department of Dermatology, Mayo Clinic, Rochester, MN, USA.|Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Camilleri
authors.affiliation: Department of Dermatology, Mayo Clinic, Rochester, MN, USA.|Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Lawrence E
authors.initials: LE
authors.lastname: Gibson
authors.affiliation: Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
authors.forename: Mark D P
authors.initials: MD
authors.lastname: Davis
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007871:Leg Ulcer / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use; D017511:Pyoderma Gangrenosum / Q000175:diagnosis* / Q000209:etiology; D000069283:Rituximab / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D007155:Immunologic Factors; D000069283:Rituximab; D011241:Prednisone